Search

everythinglearnresearchcommunity

for

Search:↓

Vismodegib can cause muscle spasms, taste changes, hair loss, fatigue, weight loss, and possibly new issues like skin cancer, dehydration, and swallowing problems, needing close monitoring.

Early diagnosis and combination therapy, especially with finasteride and dutasteride, are key to managing Frontal Fibrosing Alopecia effectively.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

Ritlecitinib is effective and safe for long-term use in treating severe alopecia areata in people aged 12 and older.

Rituximab can cause skin issues, but baricitinib may help improve them.

Platelet-Rich Plasma (PRP) therapy can effectively treat various hair loss conditions, improve hair count, thickness, and density, and potentially speed up results when combined with surgical techniques.

Patients should discuss complementary medicine use with doctors to improve health outcomes.

Minoxidil and finasteride combined can effectively treat hair loss.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

Low-dose oral minoxidil is safe for hair loss, with no link between side effects and patient demographics.

Low-dose oral minoxidil and spironolactone combo effectively reduces hair loss and improves hair density in women.

Low-level light therapy safely improves hair growth and thickness for androgenetic alopecia.

Finasteride for hair loss may cause depression, affecting sleep and relationships.

Oral dutasteride improves hair growth, reduces hair loss, and is safe for most patients.

Finasteride reduces gambling symptoms in Parkinson's patients.

Benzodiazepines changed hormone levels but did not affect hair growth in women with idiopathic hirsutism.

Enfortumab vedotin can cause skin issues, especially in older males, needing early monitoring.

Topical caffeine improves hair loss intensity, speed, and shedding, and works better with minoxidil/azelaic acid.

Tofacitinib and baricitinib are effective and safe for treating severe alopecia areata, especially in younger people.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

Androgens may block hair growth signals, targeting this could treat hair loss.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.

PRP therapy may increase hair density in pattern hair loss without serious side effects, but more research is needed.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

In Spain, dermatologists most commonly prescribe topical minoxidil and oral finasteride for male hair loss, and topical minoxidil and oral contraceptives for female hair loss. The use of oral dutasteride and oral minoxidil has significantly increased over the past three years.

Mesotherapy lacks strong evidence for effectiveness and safety, and its ingredients are not FDA-approved for subcutaneous use.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.